These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35458672)

  • 1. An Extensive Pharmacological Evaluation of New Anti-Cancer Triterpenoid (Nummularic Acid) from
    Majid M; Farhan A; Asad MI; Khan MR; Hassan SSU; Haq IU; Bungau S
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorative Effect of Structurally Divergent Oleanane Triterpenoid, 3-Epifriedelinol from
    Majid M; Farhan A; Baig MW; Khan MT; Kamal Y; Hassan SSU; Bungau S; Haq IU
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nummularic acid, a triterpenoid, from the medicinal plant Fraxinus xanthoxyloides, induces energy crisis to suppress growth of prostate cancer cells.
    Younis T; Khan MI; Khan MR; Rasul A; Majid M; Adhami VM; Mukhtar H
    Mol Carcinog; 2018 Oct; 57(10):1267-1277. PubMed ID: 29802724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways.
    Shankar E; Zhang A; Franco D; Gupta S
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28208611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of signaling pathways involved in lupeol induced inhibition of proliferation and induction of apoptosis in human prostate cancer cells.
    Prasad S; Nigam N; Kalra N; Shukla Y
    Mol Carcinog; 2008 Dec; 47(12):916-24. PubMed ID: 18404669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L; Zhu Z; Joshi B; Porter AT; Tang DG
    Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway.
    Dong F; Yang P; Wang R; Sun W; Zhang Y; Wang A; Chen M; Chen L; Zhang C; Jiang M
    Prostate; 2019 Aug; 79(11):1284-1293. PubMed ID: 31212374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells.
    Kim HR; Park CG; Jung JY
    Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
    Tang DG; Li L; Chopra DP; Porter AT
    Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
    Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
    Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retigeric acid B exhibits antitumor activity through suppression of nuclear factor-κB signaling in prostate cancer cells in vitro and in vivo.
    Liu YQ; Hu XY; Lu T; Cheng YN; Young CY; Yuan HQ; Lou HX
    PLoS One; 2012; 7(5):e38000. PubMed ID: 22666431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.
    Sanna V; Chamcheu JC; Pala N; Mukhtar H; Sechi M; Siddiqui IA
    Int J Nanomedicine; 2015; 10():6835-46. PubMed ID: 26586945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cycloartan-24-ene-1α,2α,3β-triol, a cycloartane-type triterpenoid from the resinous exudates of Commiphora myrrha, induces apoptosis in human prostatic cancer PC-3 cells.
    Gao W; Su X; Dong X; Chen Y; Zhou C; Xin P; Yu C; Wei T
    Oncol Rep; 2015 Mar; 33(3):1107-14. PubMed ID: 25591732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.
    Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX
    Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
    Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
    Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capilliposide C derived from Lysimachia capillipes Hemsl inhibits growth of human prostate cancer PC3 cells by targeting caspase and MAPK pathways.
    Li R; Zhang L; Zhang L; Chen D; Tian J; Cao L; Zhang L
    Int Urol Nephrol; 2014 Jul; 46(7):1335-44. PubMed ID: 24554216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norcantharidin induces apoptosis in human prostate cancer cells through both intrinsic and extrinsic pathways.
    Yang PY; Hu DN; Kao YH; Lin IC; Chou CY; Wu YC
    Pharmacol Rep; 2016 Oct; 68(5):874-80. PubMed ID: 27351942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo.
    Karna P; Gundala SR; Gupta MV; Shamsi SA; Pace RD; Yates C; Narayan S; Aneja R
    Carcinogenesis; 2011 Dec; 32(12):1872-80. PubMed ID: 21948980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling.
    Hafeez BB; Siddiqui IA; Asim M; Malik A; Afaq F; Adhami VM; Saleem M; Din M; Mukhtar H
    Cancer Res; 2008 Oct; 68(20):8564-72. PubMed ID: 18922932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.